Earnings History Data for Viatris (VTRS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Viatris

Viatris Inc. is a healthcare company. It provides access to medicines, advance sustainable operations, develop solutions and leverage to connect more people to more products and services through Global Healthcare Gateway(TM). Viatris Inc., formerly known as Mylan NV, is based in PITTSBURGH.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	PM		VTRS	Viatris	16,232	0.61	0.67	0.00	Viatris EPS of -$0.64, revenue of $3.83B misses by $50M [2/28/2024 6:34 AM]	12.29	-0.94 (-7.07%)	13.15	-0.08 (-0.60%)	8.74 - 13.62	23,696,357	12,710,000	169,885
Viatris secures right to late-stage drug assets in Idorsia pact [2/28/2024 6:16 AM] Viatris EPS of -$0.64, revenue of $3.83B misses by $50M [2/28/2024 6:34 AM] Viatris in charts: Net sales in Emerging markets rise 6.6% Y/Y, Brands up over 4% in Q4 [2/28/2024 7:26 AM] Viatris sets 2024 guidance above consensus; boosts share buybacks [2/28/2024 7:47 AM] Dividend rally: Top 10 large-cap performers in 2024 with at least a 3% yield [2/28/2024 12:41 PM]
07-11-2023	AH		VTRS	Viatris Inc.	11,120	0.78	0.74	0.86	Viatris GAAP EPS of $0.27 misses by $0.07, revenue of $3.94B misses by $60M [11/7/2023 4:05 PM]	9.22	0.09 (0.99%)	9.38	0.25 (2.74%)	8.74 - 12.40	13,803,466	8,110,000	19,559
AbbVie, GSK, Teva cited as FTC tackles improper Orange Book patents [11/7/2023 12:53 PM] Viatris GAAP EPS of $0.27 misses by $0.07, revenue of $3.94B misses by $60M [11/7/2023 4:05 PM] Viatris in charts: Brand revenue flat with last year; generic revenue edges higher [11/7/2023 5:03 PM]
07-08-2023	PM		VTRS	Viatris Inc.	12,530	0.75	0.71	0.88	Viatris beats Q2 top and bottom line estimates; reaffirms FY23 outlook [8/7/2023 7:04 AM]	11.01	0.42 (3.97%)	10.84	0.25 (2.36%)	8.42 - 12.40	18,401,796	9,650,000	47,827
Viatris beats Q2 top and bottom line estimates; reaffirms FY23 outlook [8/7/2023 7:04 AM] Viatris posts first topline beat in over a year as Q2 revenue improves [8/7/2023 7:43 AM] Viatris multiple sclerosis therapy accepted for FDA review [8/7/2023 8:07 AM]
08-05-2023	PM	6:50 AM ET (May 8)	VTRS	Viatris Inc.	10,800	0.78	0.69	0.93	Viatris reports Q1 results [5/8/2023 7:47 AM]	9.81	0.54 (5.77%)	9.60	0.32 (3.45%)	8.42 - 12.40	21,155,864	9,270,000	59,741
Viatris expects return to growth as Q1 topline contracts 11% [5/8/2023 7:41 AM] Viatris reports Q1 results [5/8/2023 7:47 AM]
27-02-2023	PM	6:50 AM ET (Feb 27)	VTRS	Viatris Inc.	13,930	0.69	0.69	0.80	Viatris GAAP EPS of $0.83 beats by $0.68, revenue of $3.87B misses by $120M [2/27/2023 6:05 AM]	11.21	-0.29 (-2.56%)	11.40	-0.11 (-0.96%)	8.42 - 13.74	11,468,681	8,410,000	47,528
Viatris GAAP EPS of $0.83 beats by $0.68, revenue of $3.87B misses by $120M [2/27/2023 6:05 AM] Viatris swings to $1B net earnings in Q4 thanks to biosimilar sale [2/27/2023 7:09 AM] Viatris appoints Scott A. Smith to succeed CEO Michael Goettler, effective April 1 [2/27/2023 7:55 AM]
07-11-2022	PM	7:00 AM ET (Nov 7)	VTRS	Viatris Inc.	11,730	0.86	0.82	0.99	Viatris GAAP EPS of $0.29 beats by $0.10, revenue of $4.07B misses by $70M [11/7/2022 6:53 AM]	10.95	1.25 (12.84%)	10.28	0.58 (5.98%)	8.42 - 15.60	27,081,554	8,300,000	161,883
Viatris GAAP EPS of $0.29 beats by $0.10, revenue of $4.07B misses by $70M [11/7/2022 6:53 AM] Oyster Point Pharma jumps 37% as Viatris agrees to acquire for $11/share in cash [11/7/2022 8:40 AM] Viatris nears five-month high after Oyster Pharma deal and Q3 earnings [11/7/2022 11:13 AM] Viatris declares $0.12 dividend [11/7/2022 12:37 PM] Viatris Reports Strong Third Quarter 2022 Results [Nov-07-22 06:50AM]
08-08-2022	PM	7:00 AM ET (Aug 8)	VTRS	Viatris Inc.	11,580	0.88	0.81	0.98	Viatris GAAP EPS of $0.26 beats by $0.07, revenue of $4.12B misses by $60M [8/8/2022 7:03 AM]	10.07	0.35 (3.55%)	10.20	0.47 (4.83%)	9.45 - 15.60	34,815,824	14,780,000	543,378
Viatris GAAP EPS of $0.26 beats by $0.07, revenue of $4.12B misses by $60M, lowers FY22 revenue guidance [8/8/2022 7:03 AM] Viatris declares $0.12 dividend [8/8/2022 7:38 AM] Viatris lowers 2022 guidance to reflect currency impact [8/8/2022 7:49 AM] Viatris Reports Strong Second Quarter 2022 Results [Aug-08-22 06:59AM] Viatris Q2 Preview: Can Shares Snap Their Downtrend? [Aug-05-22 03:48PM] Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline [Aug-05-22 11:53AM]
09-05-2022	PM	6:00 AM ET (May 9)	VTRS	Viatris Inc.	12,180	0.93	0.81	0.92	Viatris GAAP EPS of $0.33 beats by $0.25, revenue of $4.19B misses by $70M [5/9/2022 7:02 AM]	10.51	0.56 (5.58%)	9.99	0.04 (0.40%)	9.66 - 16.29	20,181,498	14,180,000	147,519
Viatris GAAP EPS of $0.33 beats by $0.25, revenue of $4.19B misses by $70M [5/9/2022 7:02 AM] Viatris gains despite 1Q revenue miss as cashflow tops estimates [5/9/2022 10:13 AM] Theravance's (TBPH) Q1 Earnings and Sales Miss Estimates [May-06-22 04:15PM] Viatris Reports Strong First-Quarter 2022 Results [May-09-22 06:59AM] Viatris (VTRS) Q1 Earnings Beat Estimates [May-09-22 08:25AM] Viatris outlines potential depth of share repurchases after divestitures [May-09-22 10:54AM] Why Viatris Stock Is Popping Today [May-09-22 11:55AM]
28-02-2022	PM	7:00 AM ET (Feb 28)	VTRS	Viatris Inc.	16,850	0.80	0.82	0.94	Viatris GAAP EPS of -$0.22 misses by $0.45, revenue of $4.33B misses by $10M [2/28/2022 6:04 AM]	11.02	-3.52 (-24.22%)	13.99	-0.55 (-3.78%)	10.88 - 16.29	51,605,885	9,950,000	456,068
Viatris GAAP EPS of -$0.22 misses by $0.45, revenue of $4.33B misses by $10M [2/28/2022 6:04 AM] Viatris reports Q4 results, Biocon deal; authorizes $1B stock buyback [2/28/2022 6:55 AM] Viatris sinks to a 52-week low after Q4 earnings and Biocon deal [2/28/2022 11:23 AM] Why Viatris (VTRS) Might Surprise This Earnings Season [Feb-25-22 09:07AM] India's Biocon beefs up biosimilar portfolio with $3.34 billion Viatris deal, shares fall [Feb-28-22 05:03AM] 3 Dirt-Cheap Dividend Stocks to Buy in March [Feb-28-22 05:52AM] UPDATE 1-Viatris to settle EpiPen antitrust litigation for $264 million [Feb-28-22 06:15AM] Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket [Feb-28-22 06:23AM] UPDATE 2-Viatris to settle EpiPen antitrust litigation for $264 million [Feb-28-22 06:15AM] Viatris to settle EpiPen antitrust litigation for $264 million [Feb-28-22 06:06AM] Viatris to sell off biosimilars business for $3B [Feb-28-22 07:05AM] Viatris (VTRS) Q4 Earnings Miss Estimates [Feb-28-22 07:45AM] Viatris Stock Slammed After Earnings, $3 Billion-Plus Asset Sale [Feb-28-22 10:22AM] Viatris outlines 'bold' approach for the future as stock drops 22% [Feb-28-22 11:36AM] Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble. [Feb-28-22 12:19PM] Viatris' (VTRS) Q4 Earnings Miss, Biocon Biologics Deal Inked [Feb-28-22 10:42AM] Here's Why Viatris Stock Is Sliding on Monday [Feb-28-22 01:07PM] Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver [Feb-28-22 02:15PM] Why These 10 Stocks Are Moving on Monday [Feb-28-22 02:48PM] Viatris Inc. -- Moody's: Viatris' biosimilars transaction is credit positive but tempered by core earnings pressure and ongoing cash outlays [Feb-28-22 07:52PM]
08-11-2021	PM	7:00 AM ET (Nov 8)	VTRS	Viatris Inc.	16,540	0.99	0.86	1.32	Viatris EPS of $0.26, raises guidance [11/8/2021 7:01 AM]	14.69	0.97 (7.03%)	14.40	0.67 (4.88%)	12.94 - 18.86	17,089,807	9,200,000	488,577
Viatris EPS of $0.26, raises guidance [11/8/2021 7:01 AM] Viatris tightens 2021 revenue guidance; growth momentum in net sales cools [11/8/2021 8:08 AM] Biotech Stocks' Q3 Earnings on Nov 8: VTRS, EDIT & More [Nov-05-21 10:09AM] Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022 [Nov-08-21 06:59AM] Viatris (VTRS) Q3 Earnings and Revenues Surpass Estimates [Nov-08-21 08:35AM] Viatris (VTRS) Beats on Q3 Earnings & Sales, Tweaks View [Nov-08-21 10:01AM] Were Hedge Funds Right About Viatris Inc. (VTRS)? [Nov-08-21 02:30PM] Viatris keen to increase dividends [Nov-08-21 02:16PM]
09-08-2021	PM	7:00 AM ET (Aug 9)	VTRS	Viatris Inc.	16,840	0.98	0.88	1.11	Viatris EPS beats by $0.10, beats on revenue, raises guidance [8/9/2021 7:01 AM]	15.13	0.88 (6.18%)	14.75	0.50 (3.51%)	12.94 - 18.86	14,257,932	6,680,000	145,324
Viatris EPS beats by $0.10, beats on revenue, raises guidance [8/9/2021 7:01 AM] Viatris raises 2021 guidance as quarterly revenue improves [8/9/2021 8:05 AM] Plastics Are Still in Demand. This Stock Stands to Profitbut Beware the Risks. [Aug-06-21 08:26PM] Plastics Are Still in Demand. This Stock Stands to Profitbut Beware the Risks. [Aug-06-21 06:23PM] Viatris Reports Strong Second Quarter Results [Aug-09-21 06:59AM] Viatris (VTRS) Beats on Q2 Earnings & Sales, Raises View [Aug-09-21 10:33AM] Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript [Aug-09-21 03:30PM]
10-05-2021	PM	Before the open (May 10)	VTRS	Viatris Inc.	16,840	0.92	0.79	0.90	Viatris EPS reports Q1 results [5/10/2021 7:01 AM]	15.02	0.94 (6.68%)	14.80	0.72 (5.11%)	12.94 - 19.24	27,148,779	9,860,000	603,338
Viatris declares $0.11 dividend [5/10/2021 7:01 AM] Viatris EPS beats by $0.12, beats on revenue [5/10/2021 7:01 AM] Viatris (VTRS) Q1 tops forecast; declares inaugural quarterly dividend of $0.11 [5/10/2021 7:51 AM] Viatris Inc to Host Earnings Call [May-10-21 08:15AM] Viatris Inc. Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidance and Announces Inaugural Quarterly Dividend [May-10-21 06:59AM]